MOTS-c BAC Water & Reconstitution Guide
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a mitochondrial-derived peptide being investigated for metabolic, mitochondrial, inflammatory, and cellular stress signaling. Current evidence includes preclinical research and human studies measuring naturally occurring MOTS-c, while a Phase 2a trial evaluating administered MOTS-c is currently registered.
How Much BAC Water for MOTS-c?
There is no scientifically established universal BAC-water volume for MOTS-c. The amount of diluent determines the resulting concentration. For research calculations, the relationship is straightforward:
| Hypothetical Vial Quantity | 1 mL BAC Water | 2 mL BAC Water | 2.5 mL BAC Water | 3 mL BAC Water | 5 mL BAC Water |
|---|---|---|---|---|---|
| 5 mg | 5 mg/mL | 2.5 mg/mL | 2 mg/mL | 1.67 mg/mL | 1 mg/mL |
| 10 mg | 10 mg/mL | 5 mg/mL | 4 mg/mL | 3.33 mg/mL | 2 mg/mL |
| 20 mg | 20 mg/mL | 10 mg/mL | 8 mg/mL | 6.67 mg/mL | 4 mg/mL |
Need a different vial quantity or BAC-water volume?
Use the BacScience Universal BAC Water Calculator to calculate concentration from a custom peptide quantity and liquid volume.
How Much BAC Water Should Be Added to MOTS-c?
There is no universally established BAC-water amount for MOTS-c. The correct mathematical volume depends on the concentration required for a particular research preparation and the quantity of peptide represented by the vial.
For example, if a hypothetical 10 mg quantity of MOTS-c were combined with 2 mL of liquid, the resulting mathematical concentration would be 5 mg/mL. If the same 10 mg quantity were represented in 5 mL, the mathematical concentration would be 2 mg/mL.
A concentration calculation tells you how much compound is represented per milliliter. It does not establish how much compound a person should receive, how frequently it should be administered, or whether administration is safe.
How much BAC water for MOTS-c 5 mg?
A hypothetical 5 mg quantity could produce different concentrations depending on liquid volume. For example:
- 5 mg ÷ 1 mL = 5 mg/mL
- 5 mg ÷ 2 mL = 2.5 mg/mL
- 5 mg ÷ 2.5 mL = 2 mg/mL
- 5 mg ÷ 5 mL = 1 mg/mL
These are mathematical examples only and should not be interpreted as validated MOTS-c preparation instructions.
How much BAC water for MOTS-c 10 mg?
For a hypothetical 10 mg quantity:
- 10 mg ÷ 1 mL = 10 mg/mL
- 10 mg ÷ 2 mL = 5 mg/mL
- 10 mg ÷ 2.5 mL = 4 mg/mL
- 10 mg ÷ 3 mL = 3.33 mg/mL
- 10 mg ÷ 5 mL = 2 mg/mL
How does BAC-water volume change MOTS-c concentration?
Increasing liquid volume decreases concentration because the same quantity of peptide is distributed through a larger volume. Decreasing liquid volume increases concentration.
The fundamental relationship remains:
What Is MOTS-c?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. It is a short mitochondrial-derived peptide encoded within mitochondrial DNA and is part of a group of mitochondrial-derived peptides investigated as signaling molecules involved in cellular and metabolic regulation.
Research has examined MOTS-c in relation to metabolic homeostasis, insulin sensitivity, exercise-associated signaling, oxidative stress, inflammation, and other cellular responses.
Importantly, the existence of human studies measuring naturally circulating MOTS-c should not be interpreted as evidence that administering synthetic MOTS-c has been proven safe or effective in humans.
Human biomarker studies measure MOTS-c naturally present in participants. They are fundamentally different from interventional studies in which synthetic MOTS-c is administered as an experimental treatment.
How MOTS-c Works
Preclinical research has investigated MOTS-c as a mitochondrial signaling peptide involved in cellular responses to metabolic stress. Proposed mechanisms include interactions with metabolic signaling pathways such as AMPK and pathways associated with glucose and energy homeostasis.
These mechanisms are scientifically interesting, but pathway activity observed in cells or animals does not establish a therapeutic effect in humans.
What Is MOTS-c Being Studied For?
Human observational research has examined circulating MOTS-c in metabolic health, exercise, cardiometabolic conditions, pulmonary disease, kidney disease, and other settings.
For example, researchers have measured circulating MOTS-c in healthy participants and people with conditions such as PCOS, COPD, multiple sclerosis, and kidney disease.
Human Clinical Research
Human evidence concerning MOTS-c currently requires careful interpretation. Several studies have measured endogenous circulating MOTS-c as a biomarker. These studies provide information about associations and physiology, but they do not establish the safety or efficacy of injecting synthetic MOTS-c.
A registered Phase 2a trial, NCT07505745, is now evaluating administered MOTS-c in adults with prediabetes and overweight or obesity. The registry describes a randomized, double-blind, placebo-controlled study with a 12-week treatment period and subcutaneous administration. The public record currently does not state the fixed dose, and no trial results have been posted.
No clinically established human dose has been identified from completed published clinical trials of administered MOTS-c. The currently registered Phase 2a trial is investigational and its results are not yet available.
Published Human Research Examples
| Study | Population | What Was Studied? | Evidence Type |
|---|---|---|---|
| Ramanjaneya et al., 2019 | Healthy participants and women with PCOS | Circulating MOTS-c response to lipid and insulin infusion and exercise | Human observational / physiological |
| Exercise study, 2021 | Breast cancer survivors | MOTS-c response in relation to aerobic and resistance exercise | Human research |
| COPD study | Patients with COPD | Circulating mitochondrial peptides including MOTS-c | Human observational |
| NCT07505745 | Adults with prediabetes and overweight/obesity | Administered MOTS-c versus placebo | Phase 2a interventional trial |
Doses Studied in Published Research
BacScience does not convert animal doses, community protocols, vendor instructions, or speculative calculations into human dosing recommendations.
The currently registered MOTS-c Phase 2a study specifies subcutaneous administration and a fixed once-daily regimen for 12 weeks, but the public ClinicalTrials.gov record does not disclose the numerical dose. Consequently, there is no defensible numerical human dose that this page can present as an established clinical dose.
| Study / Evidence | Population | Dose Studied | Route | Frequency / Duration | Interpretation |
|---|---|---|---|---|---|
| NCT07505745 | Adults with prediabetes and overweight/obesity | Not publicly specified in registry | Subcutaneous | Once daily / 12 weeks | Investigational trial protocol; no results posted |
| Human biomarker studies | Various human populations | No administered MOTS-c dose | Not applicable | Measurement of endogenous MOTS-c | Cannot establish therapeutic dosing |
These research findings are not BacScience dosage recommendations.
Preclinical Research
A substantial portion of the MOTS-c literature is preclinical. Experimental models have investigated metabolic regulation, mitochondrial signaling, cellular stress responses, inflammation, skeletal muscle biology, and other biological processes.
More recent laboratory research has also examined MOTS-c in inflammatory and immune contexts. For example, experimental work has investigated its effects in cellular and animal models of host defense and tissue injury.
A biological effect observed in mice, cultured cells, or other experimental systems cannot be assumed to produce the same effect, dose-response relationship, pharmacokinetics, or safety profile in humans.
MOTS-c Research Reconstitution & Concentration
In a research calculation, concentration describes the quantity of compound represented per unit volume of liquid. For mass-based peptide calculations, the standard relationship is:
Concentration Formula
mg/mL = total mg ÷ total mL
Example:
10 mg ÷ 2 mL = 5 mg/mL
The same 10 mg quantity represented in 5 mL would equal:
10 mg ÷ 5 mL = 2 mg/mL
BAC Water vs. MOTS-c Concentration
BAC-water volume and peptide concentration are mathematically linked. Increasing the volume of diluent lowers the concentration, while decreasing the volume raises it.
The total mass of peptide represented by the vial does not increase simply because additional liquid is added.
Worked Mathematical Examples
| Peptide Quantity | Liquid Volume | Calculation | Result |
|---|---|---|---|
| 5 mg | 1 mL | 5 ÷ 1 | 5 mg/mL |
| 5 mg | 2 mL | 5 ÷ 2 | 2.5 mg/mL |
| 10 mg | 2 mL | 10 ÷ 2 | 5 mg/mL |
| 10 mg | 5 mL | 10 ÷ 5 | 2 mg/mL |
These examples are provided to demonstrate concentration mathematics. They are not administration instructions.
Research Limitations & Safety
MOTS-c should be treated as an investigational research compound, not as an FDA-approved therapeutic drug.
Available regulatory information does not establish an FDA-approved MOTS-c product or approved human indication. A 2026 FDA document discussing MOTS-c also noted that searches did not identify authorized products containing MOTS-c or MOTS-c acetate.
Research interest in MOTS-c does not establish human safety, efficacy, pharmacokinetics, appropriate administration, compatibility with a particular diluent, or a safe dose.
What This Page Does Not Provide
- No human treatment recommendation.
- No individualized dosing instructions.
- No claim that MOTS-c is safe or effective for a disease.
- No conversion of animal doses into human doses.
- No community protocol presented as clinical evidence.
- No claim that a particular BAC-water volume is universally correct.
MOTS-c BAC Water & Reconstitution FAQs
How much BAC water should be added to MOTS-c?
What is the formula for MOTS-c concentration?
What concentration is 10 mg of MOTS-c in 2 mL?
What concentration is 5 mg of MOTS-c in 2 mL?
Does adding more BAC water reduce MOTS-c concentration?
Is MOTS-c FDA approved?
Has MOTS-c been studied in humans?
Is there an established human MOTS-c dose?
Are animal MOTS-c doses equivalent to human doses?
Does a concentration calculation tell me how much to administer?
Can the BacScience BAC Water Calculator calculate MOTS-c concentration?
Where can I calculate a different MOTS-c concentration?
Scientific References
The following primary and high-quality scientific resources support the scientific background and current research-status statements on this page.
-
ClinicalTrials.gov — NCT07505745
MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity (MOTS-MET). -
Ramanjaneya et al., Clinical Endocrinology, 2019
Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects. -
Scientific Reports, 2021
Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors. -
PubMed / NCBI — COPD mitochondrial peptide research
Alterations in circulating mitochondrial signals at hospital admission for COPD exacerbation. -
PubMed / NCBI — MOTS-c and mitochondrial biology
Peer-reviewed literature concerning MOTS-c, metabolic signaling, mitochondrial-derived peptides, and cellular stress. -
U.S. Food and Drug Administration
FDA regulatory information concerning MOTS-c and MOTS-c acetate.
BacScience prioritizes FDA, NIH/PubMed, ClinicalTrials.gov, peer-reviewed journals, and official regulatory materials for scientific claims. Vendor pages, forums, Reddit discussions, affiliate pages, and community protocols are not treated as evidence for clinical efficacy or validated human dosing.